Kong YY et al. |
Osteoprotegerin ligand: a regulator of immune responses and bone physiology. |
2000 |
Immunol. Today |
pmid:11071528
|
Sakuma Y et al. |
Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype. |
2000 |
Infect. Immun. |
pmid:11083800
|
Riggs BL |
The mechanisms of estrogen regulation of bone resorption. |
2000 |
J. Clin. Invest. |
pmid:11086020
|
Lee ZH et al. |
Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. |
2000 |
Mol. Pharmacol. |
pmid:11093794
|
Takami M et al. |
Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. |
2000 |
Endocrinology |
pmid:11108286
|
Gori F et al. |
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. |
2000 |
Endocrinology |
pmid:11108292
|
Miyamoto T et al. |
An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. |
2000 |
Blood |
pmid:11110710
|
|
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature. |
2000 |
Bone |
pmid:11113385
|
Takayanagi H et al. |
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. |
2000 |
Nature |
pmid:11117749
|
Mancini L et al. |
Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11118297
|